PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Kobe City Hospital Organization, Kobe City Medical Center General Hospital, Kobe, Japan.\', \'Faculty of Pharmaceutical Science, Kobe Gakuin University, Kobe, Japan.\', \'Department of Respiratory Medicine, Kobe City Hospital Organization, Kobe City Medical Center General Hospital, Kobe, Japan.\', \'Department of Clinical Laboratory, Kobe City Hospital Organization, Kobe City Medical Center General Hospital, Kobe, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/psp4.12685
?:doi
?:hasPublicationType
?:journal
  • CPT: pharmacometrics & systems pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34292670
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Population pharmacokinetics of favipiravir in patients with COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34292670>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34292670>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all